TY  - JOUR
AU  - Sanfilippo, Roberta
AU  - Jones, Robin L
AU  - Blay, Jean-Yves
AU  - Le Cesne, Axel
AU  - Provenzano, Salvatore
AU  - Antoniou, Georgios
AU  - Mir, Olivier
AU  - Fucà, Giovanni
AU  - Fumagalli, Elena
AU  - Bertulli, Rossella
AU  - Stacchiotti, Silvia
AU  - Brahmi, Mehdi
AU  - Grosso, Federica
AU  - Dufresne, Armelle
AU  - Hindi, Nadia
AU  - Sbaraglia, Marta
AU  - Gronchi, Alessandro
AU  - Collini, Paola
AU  - Dei Tos, Angelo P
AU  - Casali, Paolo G
PY  - 2019
DO  - 10.1158/1078-0432.CCR-19-0288
UR  - http://hdl.handle.net/10668/14145
T2  - Clinical cancer research : an official journal of the American Association for Cancer Research
AB  - Perivascular epitheliod cell tumors (PEComas) are rare mesenchymal neoplasms for which the role of systemic treatments is not established as there are no published prospective clinical trials or sufficiently large retrospective case series. The aim of...
LA  - en
KW  - Adult
KW  - Aged
KW  - Anthracyclines
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - Deoxycytidine
KW  - Everolimus
KW  - Female
KW  - Humans
KW  - Indazoles
KW  - International Agencies
KW  - Male
KW  - Middle Aged
KW  - Perivascular Epithelioid Cell Neoplasms
KW  - Prognosis
KW  - Pyrimidines
KW  - Retrospective Studies
KW  - Sirolimus
KW  - Sorafenib
KW  - Sulfonamides
KW  - Survival Rate
KW  - TOR Serine-Threonine Kinases
KW  - Vascular Endothelial Growth Factor Receptor-1
KW  - Gemcitabine
TI  - Role of Chemotherapy, VEGFR Inhibitors, and mTOR Inhibitors in Advanced Perivascular Epithelioid Cell Tumors (PEComas).
TY  - research article
VL  - 25
ER  -